Emergent BioSolutions (EBS) Work In Process (2011 - 2018)

Emergent BioSolutions' Work In Process history runs 8 years deep, the most recent figure standing at $103.2 million for Q4 2018.

• On a quarterly basis, Work In Process rose 34.73% year-over-year to $103.2 million in Q4 2018; TTM through Dec 2018 was $103.2 million, a 34.73% increase from a year earlier, with the FY2018 full-year figure at $103.2 million, up 34.73% from the prior year.
• Work In Process advanced to $103.2 million in Q4 2018 per EBS's latest filing, from $64.8 million in the prior quarter.
• Across five years, Work In Process topped out at $103.2 million in Q4 2018 and bottomed at $14.8 million in Q3 2017.
• The 5-year median for Work In Process is $34.0 million (2014), against an average of $44.1 million.
• Across the five-year window, Work In Process plunged 39.59% in 2017 and surged 338.72% in 2018, its largest moves.
• Year by year, Work In Process stood at $33.5 million in 2014, then dropped by 2.29% to $32.7 million in 2015, then tumbled by 39.4% to $19.8 million in 2016, then soared by 286.46% to $76.6 million in 2017, then jumped by 34.73% to $103.2 million in 2018.
• Per Business Quant, the three latest EBS Work In Process figures stand at $103.2 million (Q4 2018), $64.8 million (Q3 2018), and $79.5 million (Q2 2018).